Literature DB >> 14996777

Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.

Martha L Bruce1, Thomas R Ten Have, Charles F Reynolds, Ira I Katz, Herbert C Schulberg, Benoit H Mulsant, Gregory K Brown, Gail J McAvay, Jane L Pearson, George S Alexopoulos.   

Abstract

CONTEXT: Suicide rates are highest in late life; the majority of older adults who die by suicide have seen a primary care physician in preceding months. Depression is the strongest risk factor for late-life suicide and for suicide's precursor, suicidal ideation.
OBJECTIVE: To determine the effect of a primary care intervention on suicidal ideation and depression in older patients. DESIGN AND
SETTING: Randomized controlled trial known as PROSPECT (Prevention of Suicide in Primary Care Elderly: Collaborative Trial) with patient recruitment from 20 primary care practices in New York City, Philadelphia, and Pittsburgh regions, May 1999 through August 2001. PARTICIPANTS: Two-stage, age-stratified (60-74, > or =75 years) depression screening of randomly sampled patients; enrollment included patients who screened positive and a random sample of screened negative patients. This analysis included patients with a depression diagnosis (N = 598). INTERVENTION: Treatment guidelines tailored for the elderly with care management compared with usual care. MAIN OUTCOME MEASURES: Assessment of suicidal ideation and depression severity at baseline, 4 months, 8 months, and 12 months.
RESULTS: Rates of suicidal ideation declined faster (P =.01) in intervention patients compared with usual care patients; at 4 months, in the intervention group, raw rates of suicidal ideation declined 12.9% points (29.4% to 16.5%) compared with 3.0% points (20.1% to 17.1% in usual care [P =.01]). Among patients reporting suicidal ideation, resolution of ideation was faster among intervention patients (P =.03); differences peaked at 8 months (70.7% vs 43.9% resolution; P =.005). Intervention patients had a more favorable course of depression in both degree and speed of symptom reduction; group difference peaked at 4 months. The effects on depression were not significant among patients with minor depression unless suicidal ideation was present.
CONCLUSIONS: Evidence of the intervention's effectiveness in community-based primary care with a heterogeneous sample of depressed patients introduces new challenges related to its sustainability and dissemination. The intervention's effectiveness in reducing suicidal ideation, regardless of depression severity, reinforces its role as a prevention strategy to reduce risk factors for suicide in late life.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996777     DOI: 10.1001/jama.291.9.1081

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  299 in total

1.  Depression and its correlates among older adults accessing aging services.

Authors:  Thomas M Richardson; Bruce Friedman; Carol Podgorski; Kerry Knox; Susan Fisher; Hua He; Yeates Conwell
Journal:  Am J Geriatr Psychiatry       Date:  2012-04       Impact factor: 4.105

2.  The role of physicians in advocating for a national strategy for suicide prevention.

Authors:  Paul S Links
Journal:  CMAJ       Date:  2011-10-17       Impact factor: 8.262

3.  Screening depression aging services clients.

Authors:  Thomas M Richardson; Hua He; Carol Podgorski; Xin Tu; Yeates Conwell
Journal:  Am J Geriatr Psychiatry       Date:  2010-12       Impact factor: 4.105

4.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

5.  A randomized trial to reduce the prevalence of depression and self-harm behavior in older primary care patients.

Authors:  Osvaldo P Almeida; Jane Pirkis; Ngaire Kerse; Moira Sim; Leon Flicker; John Snowdon; Brian Draper; Gerard Byrne; Robert Goldney; Nicola T Lautenschlager; Nigel Stocks; Helman Alfonso; Jon J Pfaff
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

6.  Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.

Authors:  Eric J Lenze; Benoit H Mulsant; Daniel M Blumberger; Jordan F Karp; John W Newcomer; Stewart J Anderson; Mary Amanda Dew; Meryl A Butters; Jacqueline A Stack; Amy E Begley; Charles F Reynolds
Journal:  Lancet       Date:  2015-09-27       Impact factor: 79.321

Review 7.  Cognitive functioning and late-life depression.

Authors:  Aaron M Koenig; Rishi K Bhalla; Meryl A Butters
Journal:  J Int Neuropsychol Soc       Date:  2014-03-31       Impact factor: 2.892

8.  A Review of Brain Stimulation Treatments for Late-Life Depression.

Authors:  Daniel M Blumberger; Jonathan H Hsu; Zafiris J Daskalakis
Journal:  Curr Treat Options Psychiatry       Date:  2015-09-28

9.  Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT).

Authors:  Hillary R Bogner; Knashawn H Morales; Edward P Post; Martha L Bruce
Journal:  Diabetes Care       Date:  2007-08-23       Impact factor: 19.112

10.  Baseline patient characteristics and mortality associated with longitudinal intervention compliance.

Authors:  Julia Y Lin; Thomas R Ten Have; Hillary R Bogner; Michael R Elliott
Journal:  Stat Med       Date:  2007-12-10       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.